SWAlexander
Senior Member
- Messages
- 1,952
Excerpt:
Four years after the COVID-19 pandemic began, Long COVID remains an unsolved, complex and urgent healthcare crisis. According to the Centers for Disease Control and Prevention, 1 in 9 adults in the United States who have ever had COVID-19 continue to experience Long COVID with a wide range of symptoms. Many symptoms are debilitating, affecting patients’ ability to work and go to school. To bolster Long COVID research efforts, NIH is investing an additional $515 million over the next four years into the Researching COVID to Enhance Recovery (RECOVER) Initiative(link is external), a nationwide research program to fully understand, diagnose and treat Long COVID. Launched in 2021 with $1.15 billion in Congressional appropriations, the RECOVER Initiative is taking a systematic, comprehensive and rigorous approach to improve our understanding of Long COVID and increase the odds of identifying treatments that work.
Infection-associated chronic conditions, such as Long COVID, have been notoriously difficult to solve. Despite years of research, the underlying biological mechanisms for conditions such as myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), Post-Treatment Lyme Disease Syndrome and a host of other infection-associated chronic conditions have not been identified, and many symptoms of these conditions remain difficult to treat. However, unlike some infection-associated chronic conditions for which the source of infection is unknown, we know that Long COVID is caused by the SARS-CoV-2 virus, which may prove advantageous in research.
continue: https://www.nih.gov/about-nih/who-w...research-efforts-through-infusion-515-million
Four years after the COVID-19 pandemic began, Long COVID remains an unsolved, complex and urgent healthcare crisis. According to the Centers for Disease Control and Prevention, 1 in 9 adults in the United States who have ever had COVID-19 continue to experience Long COVID with a wide range of symptoms. Many symptoms are debilitating, affecting patients’ ability to work and go to school. To bolster Long COVID research efforts, NIH is investing an additional $515 million over the next four years into the Researching COVID to Enhance Recovery (RECOVER) Initiative(link is external), a nationwide research program to fully understand, diagnose and treat Long COVID. Launched in 2021 with $1.15 billion in Congressional appropriations, the RECOVER Initiative is taking a systematic, comprehensive and rigorous approach to improve our understanding of Long COVID and increase the odds of identifying treatments that work.
Infection-associated chronic conditions, such as Long COVID, have been notoriously difficult to solve. Despite years of research, the underlying biological mechanisms for conditions such as myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), Post-Treatment Lyme Disease Syndrome and a host of other infection-associated chronic conditions have not been identified, and many symptoms of these conditions remain difficult to treat. However, unlike some infection-associated chronic conditions for which the source of infection is unknown, we know that Long COVID is caused by the SARS-CoV-2 virus, which may prove advantageous in research.
continue: https://www.nih.gov/about-nih/who-w...research-efforts-through-infusion-515-million